Immunological and Biochemical Modulation in the Treatment of Advanced Colorectal Cancer: Update and Future Directions
- 1 January 1996
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinomaEuropean Journal Of Cancer, 1995
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trialsEuropean Journal Of Cancer, 1994
- Appraisal of a model for prediction of prognosis in advanced colorectal cancerEuropean Journal Of Cancer, 1994
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Combination chemoimmunotherapy for metastatic colorectal cancer using 5-fluorouracil, leucovorin and interleukin-2European Journal Of Cancer, 1993
- Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaEuropean Journal Of Cancer, 1992
- Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acidEuropean Journal Of Cancer, 1992
- Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancerEuropean Journal Of Cancer, 1992
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957